Highlights KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Real-time Estimate Cboe BZX Other stock markets 03:26:16 2024-05-23 pm EDT			5-day change	1st Jan Change
2.19 ^USD	-1.79%		-7.20%	-10.79%

May. 14	KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic	CI
May. 01	Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic	May. 14	CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M	May. 01	MT
KORU Medical Systems, Inc. reaffirms Financial Guidance for the Full Year of 2024	May. 01	CI
KORU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 13	CI
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 13	CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M	Mar. 13	MT
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024	Mar. 13	CI
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic	Mar. 11	CI
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin	Mar. 06	CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $7M, vs. Street Est of $7.9M	Nov. 08	MT
KORU Medical Systems, Inc. Announces Development Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System	Nov. 08	CI
KORU Medical Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes	Nov. 07	CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q2 Revenue $6.9M, vs. Street Est of $7.2M	23-08-09	MT
KORU Medical Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
KORU Medical Systems, Inc. Updates Revenue Guidance for the Full Year 2023	23-08-09	CI
KORU Medical Systems, Inc. Provides Revenue Guidance for the Full Year 2023	23-08-02	CI
KORU Medical Systems, Inc. Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic	23-07-27	CI
Koru Medical Systems Submits Premarket Notification With US FDA for Use of Freedom60 Infusion System With Hizentra	23-07-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Highlights

Filters